KDA
ABBV icon

Kraft Davis & Associates’s AbbVie ABBV Stock Holding History

Kraft Davis & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$264K Sell
933
-11
-1% -$2.82K 0.06% 123
2026
Q2 		$239K Hold
944
– – 0.05% 139
2026
Q1 		$201K Sell
944
-261
-22% -$57.9K 0.04% 150
2025
Q4 		$266K Buy
+1,205
New +$275K 0.06% 130

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Kraft Davis & Associates's ABBV Position: Q3 2026 in Review

Kraft Davis & Associates reduced its AbbVie (ABBV) stake by 1.2% in Q3 2026, selling an estimated $2.82K and leaving 933 shares worth $264K. The position accounts for 0.06% of the portfolio, ranked #123.

Kraft Davis & Associates first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $266K in Q4 2025. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Kraft Davis & Associates held 933 shares of AbbVie worth $264K as of Q3 2026.
  • Kraft Davis & Associates sold 11 AbbVie shares in Q3 2026, an estimated $2.82K.
  • AbbVie made up 0.06% of Kraft Davis & Associates's portfolio in Q3 2026, its #123 holding.
  • Kraft Davis & Associates first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Kraft Davis & Associates's AbbVie position peaked at $266K in Q4 2025.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Kraft Davis & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.